Published on
April 20, 2021
- 12:00 GMT
Betaliq Initiates Enrollment of Phase 2 Clinical Trial For The Treatment of Glaucoma or Ocular Hypertension
Betaliq Initiates Enrollment of Phase 2 Clinical Trial Investigating BTQ-1901-A, BTQ 1901 B and BTQ-1902 For The Treatment of Glaucoma or Ocular Hypertension TAMPA, FL, UNITED STATES, April 20, 2021 /EINPresswire.com/ -- Betaliq, Inc., a clinical-stage …
Distribution channels:
Business & Economy, Companies
...
